药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Embutramide
Abaloparatide
The therapeutic efficacy of Abaloparatide can be decreased when used in combination with Dacomitinib.
Embutramide
Tiratricol
The therapeutic efficacy of Tiratricol can be decreased when used in combination with Dacomitinib.
Embutramide
3,5-Diiodotyrosine
The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Dacomitinib.
Embutramide
Emapalumab
The metabolism of Dacomitinib can be increased when combined with Emapalumab.
Embutramide
Siltuximab
The metabolism of Dacomitinib can be increased when combined with Siltuximab.
Embutramide
Secukinumab
The metabolism of Dacomitinib can be increased when combined with Secukinumab.
Embutramide
Certolizumab pegol
The metabolism of Dacomitinib can be increased when combined with Certolizumab pegol.
Embutramide
Golimumab
The metabolism of Dacomitinib can be increased when combined with Golimumab.
Embutramide
Rilonacept
The metabolism of Dacomitinib can be increased when combined with Rilonacept.
Embutramide
Tocilizumab
The metabolism of Dacomitinib can be increased when combined with Tocilizumab.
Embutramide
Canakinumab
The metabolism of Dacomitinib can be increased when combined with Canakinumab.
Embutramide
Afelimomab
The metabolism of Dacomitinib can be increased when combined with Afelimomab.
Embutramide
Choline salicylate
The risk or severity of adverse effects can be increased when Dacomitinib is combined with Choline salicylate.
Embutramide
Nafamostat
The risk or severity of adverse effects can be increased when Dacomitinib is combined with Nafamostat.
Embutramide
Ilaprazole
Ilaprazole can cause a decrease in the absorption of Dacomitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Embutramide
Dexrabeprazole
Dexrabeprazole can cause a decrease in the absorption of Dacomitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Embutramide
Dexlansoprazole
Dexlansoprazole can cause a decrease in the absorption of Dacomitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Embutramide
Avatrombopag
The metabolism of Dacomitinib can be increased when combined with Avatrombopag.
Embutramide
Dexloxiglumide
The metabolism of Dacomitinib can be decreased when combined with Dexloxiglumide.
Embutramide
Tienilic acid
The metabolism of Dacomitinib can be decreased when combined with Tienilic acid.